Showing results (841-850 of 902) with videos related to

Sort By:
Pageof 91
Journal of the National Cancer Institute|August 18, 2021
Clinicopathological and Molecular Characteristics of Early-Onset Stage III Colon Adenocarcinoma: An Analysis of the ACCENT DatabaseZhaohui Jin, Jesse G Dixon, Jack M Fiskum, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 14, 2015
Neuroendocrine tumors, version 1.2015Matthew H Kulke, Manisha H Shah, Al B Benson, et al.
JCO Precision Oncology|June 1, 2023
Prevalence and Clinical Implications of Mismatch Repair-Proficient Colorectal Cancer in Patients With Lynch SyndromeMegha Ranganathan, Rosalba E Sacca, Magan Trottier, et al.
The New England Journal of Medicine|June 6, 2022
PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal CancerAndrea Cercek, Melissa Lumish, Jenna Sinopoli, et al.
The Oncologist|March 12, 2022
Survival After Induction Chemotherapy and Chemoradiation Versus Chemoradiation and Adjuvant Chemotherapy for Locally Advanced Rectal CancerJin K Kim, Michael R Marco, Campbell S D Roxburgh, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 9, 2012
Neuroendocrine tumorsMatthew H Kulke, Al B Benson, Emily Bergsland, et al.
International Journal of Radiation Oncology, Biology, Physics|November 13, 2024
Clinical Outcomes, Patterns of Failure, and Salvage Therapies of a Large Modern Cohort of Patients With Anal Squamous Cell Carcinoma Treated With Definitive-Intent Intensity-Modulated Radiation TherapyDiana A Roth O'Brien, Vasilis C Hristidis, Zakaria Chakrani, et al.
JNCI Cancer Spectrum|May 23, 2022
Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical TrialsNadine J McCleary, William S Harmsen, Ellana Haakenstad, et al.
Diseases of the Colon and Rectum|January 14, 2025
Correlation Between Grade of Clinical Response to Neoadjuvant Therapy for Rectal Cancer and Oncologic Outcomes in the Era of Watch-and-WaitRoni Y Rosen, Aron P Bercz, Dana M Omer, et al.
European Journal of Cancer (Oxford, England : 1990)|March 16, 2020
Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiativeRomain Cohen, Dewi Vernerey, Carine Bellera, et al.
Pageof 91